Your product is now available from Integrated DNA Technologies.
Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.
xGen NGS—made for you.
Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.
Find Archer now at IDT!
All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.
Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.
CRISPR systems enable targeted editing in a wide variety of organisms by introducing single- or double-strand breaks (DSBs) to DNA, which can be leveraged to introduce genomic changes. However, unintended DSBs can occur off-target at genomic loci with partial complementarity to CRISPR-Cas guide RNA (gRNA) sequences, which can result in genotype/phenotype changes in the edited cells. Genome editing at on- and off-target sites can be quantified with multiplexed targeted next-generation sequencing (NGS) but requires bioinformatics expertise to analyze. Here we present the rhAmpSeq CRISPR Analysis System as a streamlined end-to-end solution for designing assays, generating sequencing libraries, and analyzing NGS data for quantifying CRISPR on- and off-target editing effects without the need for bioinformatics experience.
Published on: March 31, 2021